ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 191

Associations of Self-Reported Inhalant Exposures with Autoantibodies and Disease Severity in U.S. Veterans with Rheumatoid Arthritis

Ariadne Ebel1, Jill Poole 2, Geoffrey Thiele 3, Joshua Baker 4, Grant Cannon 5, Angelo Gaffo 6, Gail Kerr 7, Andreas Reimold 8, John S. Richards 9, Pescale Schwab 10, Namrata Singh 11, Dana Ascherman 12, Ted Mikuls 3 and Bryant England 13, 1University of Nebraska, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA Medical Center and Univeristy of Utah, Salt Lake City, UT, 6University of Alabama at Birmingham, Birmingham, AL, 7Washington DC VA Medical Center, Georgetown and Howard Universities, Washington DC, DC, 8UT Southwestern Medical Center, Dallas, 9VA Pittsburgh Healthcare System, Pittsburgh, PA, 10VA Portland Healthcare System, Porland, 11University of Iowa, Iowa City, 12University of Pittsburgh, Pittsburgh, 13VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: rheumatoid arthritis (RA) and anti-CCP antibodies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Epidemiology & Public Health Poster I: RA

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Cigarette smoke is a known inhalant exposure that contributes substantially to the risk and severity of rheumatoid arthritis (RA). Less is known about the link between other inhalant exposures and RA related factors. The aim of this study was to determine the association between inhalant exposures (occupational, agricultural, and military) with RA-related autoantibodies and severity in U.S. Veterans with RA.

Methods: Participants at 9 sites in the Veterans Affairs Rheumatoid Arthritis (VARA) Registry, a multicenter, longitudinal observational cohort of U.S. Veterans with RA, were mailed surveys assessing occupational, agricultural, and military inhalant exposures. Demographics, disease activity, functional status, and extra-articular features were obtained from the VARA registry database while HLA-DRB1 shared epitope (SE) status, anti-CCP antibodies, and rheumatoid factor (RF) were measured using banked serum from VARA enrollment. Cross sectional associations between self-reported inhalant exposures and RA-related factors (autoantibodies, severity, extra-articular features) were assessed using multivariable linear and logistic regression models adjusting for age, sex, race, and tobacco use. Associations between inhalant exposures and autoantibody status were further examined in models stratified by SE status.

Results: Of 1566 registry participants mailed surveys, 797 returned completed surveys (50.9% response rate). Responders were older, more frequently white, less frequently current smokers, and had better disease activity and functional status. Self-reported occupational dust exposures were present in 67.6%, living or working on a farm in 44.8%, Agent Orange exposure in 29.2%, and military burn pit exposure in 18.6%. Military service periods between 1965-1973 were most common among those self-reporting burn pit exposure, with 19% serving during periods characterized by open-air burn pits on military bases. There were no significant associations between occupational dust, farm, or Agent Orange exposures with RA autoantibodies or disease severity. Self-reported burn pit exposure was significantly associated with anti-CCP positivity (odds ratio [OR] 2.22, 95% CI 1.23-3.99) and higher anti-CCP concentrations (log-transformed; b0.50, 95% CI 0.07-0.93) independent of tobacco use. In analyses stratified by SE status, these associations were limited to individuals with SE alleles (Table 1). In models examining combined self-reported burn pit exposure and SE status, those with both risk factors demonstrated a substantially higher risk of anti-CCP positivity (OR 8.56, 95% CI 3.46-21.20) compared to either risk factor in isolation (Table 2). Self-reported burn pit exposure was not associated with RF positivity, disease activity, or extra-articular disease.

Conclusion: Self-reported burn pit exposure was associated with anti-CCP antibodies in those with HLA-DRB1 SE alleles independent of, and to a similar degree as tobacco use. While limited by the cross-sectional design and self-report exposure history, these findings suggest that other inhalant exposures may similarly influence RA autoantibody expression and confer risk for RA


Table 1

Association of self-reported burn pit exposure with anti-CCP antibody status and concentration by shared epitope status


Table 2

Association of combined self-reported burn pit exposure and shared epitope status on anti-CCP antibody positivity in RA.


Disclosure: A. Ebel, None; J. Poole, None; G. Thiele, None; J. Baker, Bristol-Myers Squibb, 2, 5, Burns-White LLC, 5; G. Cannon, Amgen, 2; A. Gaffo, Amgen, 2; G. Kerr, N/A (Received in the past for asymptomatic hyperuricemia and ultrasound study), 2, Novartis, 2; A. Reimold, None; J. Richards, None; P. Schwab, None; N. Singh, None; D. Ascherman, None; T. Mikuls, BMS, 2, Horizon, 2; B. England, None.

To cite this abstract in AMA style:

Ebel A, Poole J, Thiele G, Baker J, Cannon G, Gaffo A, Kerr G, Reimold A, Richards J, Schwab P, Singh N, Ascherman D, Mikuls T, England B. Associations of Self-Reported Inhalant Exposures with Autoantibodies and Disease Severity in U.S. Veterans with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/associations-of-self-reported-inhalant-exposures-with-autoantibodies-and-disease-severity-in-u-s-veterans-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-self-reported-inhalant-exposures-with-autoantibodies-and-disease-severity-in-u-s-veterans-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology